Blaze Penn

Stock/Crypto Investor

Predicted $TNXP to go from $0.15 to $61.57

[Blaze Penn @BlazePenn]

LONG TERM STOCK BUY (NOT SHORT TERM)

$TNXP (VERY HIGH POTENTIAL)🚨

Current Price: 18.83
Volume: 452k
Market Cap: 129.5

What is TNXP?

Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing, discovering and licensing diagnostics and therapeutics to prevent and treat human diseases. They mainly specialize in immunology, infectious disease, rare disease, and central nervous system treatment.

TNXP up and coming developments and services

TNX-102 SL: Non-opioid analgesic for fibromyalgia management. Two phase III studies have been completed, with an FDA approval aimed for August 15th, 2025

TNX-1300: Biologic for cocaine intoxication and overdose, currently in Phase II with a breakthrough therapy designation

TNX-1500: Monoclonal antibody targeting CD4OL, being developed for the prevention of allograft rejection and treatment of autoimmune diseases

TNX-801: Vaccine candidate for Mpox, shown to provide protection against the clade 1 monkeypox virus, preventing disease, lesions, and decreasing viral shedding in the mouth and lungs of animals

TNX-4200: broad spectrum antiviral program that is in contract with the US department of defense

TONIX ONE Platform: Tonix launched a digital program called Tonix one to help patients better manage and understand their condition. The program educates patients with resources and connects their patients via telemedicine

Migraine remedies: Tonix has two FDA approved medications for acute migraines, Zembrace Symtouch and Tosymra.

Why I think TNXP is a great long term stock buy

- Their fibromyalgia drug TNX-102 SL has the potential to be the first fibromyalgia treatment option in 15 years, and about 500 million people worldwide suffer from this condition

- Even though, pending FDA approval on August 15th, they already received fast track designation, which basically expedites or speeds up the process of FDA approval which is extremely good news, and if passed, could add an explosion of revenue for the company

- According to two stock analysts on https://t.co/k1iset4wfh the 12 month target price is $585, with low of $70 and a high of $1,000

[Blaze Penn @BlazePenn]

Could $SLS be the next biotech company to have a huge bull run? With shares rising significantly in the past 3 months due to high anticipation for the upcoming, final overall-survival data from its Phase 3 REGAL trial of galinpepimut-S (GPS) and also having encouraging results for SLS009 in relapsed/refractory AML showing strong response rates, which has been driving further investor interest.

[Blaze Penn @BlazePenn]

$SLS to the moon?!

[Blaze Penn @BlazePenn]

@significant2025 Months ago

[Blaze Penn @BlazePenn]

Could $DVLT be the next $TNXP?breaking out from 20 cents to $70, $DVLT has already went from 28 cents to $1.53 this month, and has a lot of bullish news

[Blaze Penn @BlazePenn]

$HCTI

[Blaze Penn @BlazePenn]

$IPDN

[Blaze Penn @BlazePenn]

Anyone else sell #AGMH too early? Rough day man😞

[Blaze Penn @BlazePenn]

$PBM

[Blaze Penn @BlazePenn]

$VGZ

[Blaze Penn @BlazePenn]

$VSTD

[Blaze Penn @BlazePenn]

Anyone catch $ISPC and $QMMM ?

[Blaze Penn @BlazePenn]

$MMA

[Blaze Penn @BlazePenn]

No good trading stocks today, stay away from market today

[Blaze Penn @BlazePenn]

$NBY

[Blaze Penn @BlazePenn]

All you have to do to become a consistently profitable day trader is to watch the Stocktwits top gainers, seek out which stocks have the biggest daily volume/to the days volume and wait around 5 minutes and then you buy

[Blaze Penn @BlazePenn]

$WKSP tmrw👀👀

[Blaze Penn @BlazePenn]

Keep your eyes on $CIFR and $SOGP

[Blaze Penn @BlazePenn]

It might be a good time to short $TNXP and $NEGG unfortunately

[Blaze Penn @BlazePenn]

$ANTE